Press Releases
Newsletters
AGT Newsletter Volume 10
VOLUME 10 September 2020 Newsletter We’ve achieved a number of significant milestones this quarter, including the Food and Drug Administration (FDA) clearance to begin Phase 1 of our HIV cure program. The excit...
AGT Newsletter Volume 9
VOLUME 9 May 2020 Newsletter FDA Progress The Path to the Clinic For the HIV Cure This month, AGT saw tremendous progress with the FDA. FDA time and attention to our project has seemed to increase while agency...
Happy New Year! AGT Newsletter – 2020 Edition
A STELLAR 2019 Has Positioned AGT For A SPECTACULAR 2020. I wanted to take a moment to sum up a great year of progress and success at AGT and to talk about potential milestones and significant inflection points ...
AGT Newsletter Volume 8
Featured Stories AGT’s HIV cure program is nearing a major milestone: Investigational New Drug (IND) submission. The IND is the key document that reports the safety data the FDA requires prior to a human trial...
Latest Videos
Published Articles
Latest From The Blog
Join Our Newsletter
Subscribe to our newsletter to keep up to date with all the latest news about AGT!
Latest AGT Tweets
#Cancer has taken a toll on our loved ones and/or ourselves. AGT #scientists are hard at work developing a genetic drug to kill epithelial solid tumors. Let's believe in the possibility of cures for those cancers.
Where there is a will, there is a way.
https://t.co/JtQrbOTPXh
What Is Gene Editing? How It Works In 2-Minutes https://t.co/rzSn7Oedew
#CRISPR $CRISPR #GeneEditing
